Article
[Epidemiology of FGF23-related hypophosophatemic diseases].
Clinical calcium - 1 Feb 2016
Endo Itsuro
Abstract excerpt
Through the studies of patients with hypophosphatemic rickets/osteomalacia, fibroblast growth factor 23(FGF23)has emerged as a humoral factor that reduces serum phosphate. Discovery of FGF23 as an essential regulator of phosphate homeostasis has markedly improved our understanding of phosphate homeostasis and hypophosphatemic or hyperphosphatemic disorders. A nationwide epidemiologic survey of FGF23-related...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
